Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-05-27 @ 7:02 AM
Study NCT ID:
NCT01336218
Status:
COMPLETED
Last Update Posted:
2011-07-22
First Post:
2011-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D4300C00015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Kelli Craven, MD, PI
Old Organization:
Quintiles, Overland Park, volunteer recruitment